Senti Biosciences is a clinical-stage company built around "logic-gated" cell and gene therapies, using engineered gene circuits designed to help therapies distinguish cancer cells from healthy tissue. Its most advanced asset, SENTI-202, is an allogeneic CAR-NK cell therapy aimed at acute myeloid leukemia and …
Core One Labs is a research-and-development company focused on psychedelic medicine, including biosynthetic production of psilocybin and delivery-technology platforms, alongside interests spanning natural health products and medical clinics. Its shares historically traded in Canada on theCanadian Securities Exchange (CSE)and in the U.S. over-the-counter market. …
SailPoint, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on September 10, 2026, covering the fiscal quarter ended July 31, 2026, and disclosing revenue, operating losses, and balance sheet figures for the period.
Build-A-Bear Workshop, Inc. filed its Form 10-Q with the SEC on September 10, 2026, covering the thirteen and twenty-six weeks ended August 1, 2026, and reporting net income of $8,760 thousand for the second quarter and $27,059 thousand for the first half of fiscal …
IBEX Limited filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 10, 2026, covering the fiscal year ended June 30, 2026.
IBEX Limited filed a Form 8-K on September 10, 2026, disclosing two credit agreement amendments executed on September 8, 2026, and announcing the release of financial results for its fourth quarter and fiscal year ended June 30, 2026.
Palo Alto Networks, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 10, 2026, covering the fiscal year ended July 31, 2026.
Nano-X Imaging develops digital X-ray and medical-imaging technology, most notably the Nanox.ARC, a multi-source tomosynthesis system built around its cold-cathode digital X-ray source, along with AI-based image-analysis applications and a teleradiology arm. Through 2026 the company has focused on commercialising that hardware and software. …
22nd Century Group manufactures, distributes and sells proprietary reduced-nicotine tobacco products and provides contractManufacturingfor other tobacco brands. Its flagship is VLN, a cigarette engineered to contain far less nicotine, marketed under an FDA Modified Risk Tobacco Product framework as a harm-reduction option. Through 2026 …
GeoVax, based in Atlanta, develops vaccines and immunotherapies using its Modified Vaccinia Ankara (MVA) platform. On August 27, 2026, the company disclosed it had received a delisting determination from Nasdaq. According to its subsequent 8-K, GOVX's closing bid price stayed below the $1.00 minimum …